Total Payments
$745,512
2024 Payments
$330.78
Companies
27
Transactions
160
Medicare Patients
1,790
Medicare Billing
$215,516
Payment Breakdown by Category
Research$722,998 (97.0%)
Other$19,508 (2.6%)
Food & Beverage$2,678 (0.4%)
Consulting$200.00 (0.0%)
Education$129.08 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $722,998 | 64 | 97.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,508 | 1 | 2.6% |
| Food and Beverage | $2,678 | 90 | 0.4% |
| Consulting Fee | $200.00 | 1 | 0.0% |
| Education | $129.08 | 4 | 0.0% |
Payments by Type
Research
$722,998
64 transactions
General
$22,515
96 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Integra LifeSciences Corporation | $447,792 | 38 | $0 (2023) |
| PolarityTE, Inc. | $133,161 | 20 | $0 (2021) |
| Celgene Corporation | $72,661 | 1 | $0 (2017) |
| TEI Medical Inc. | $37,341 | 5 | $0 (2019) |
| Ipsen Innovation | $32,363 | 13 | $0 (2021) |
| Osiris Therapeutics Inc. | $19,864 | 10 | $0 (2019) |
| Smith+Nephew, Inc. | $825.75 | 23 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $418.05 | 20 | $0 (2024) |
| ETS Wound Care LLC | $279.99 | 2 | $0 (2023) |
| Novo Nordisk Inc | $129.08 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.78 | 11 | Urgo Medical North America, LLC ($122.80) |
| 2023 | $768.30 | 16 | ETS Wound Care LLC ($279.99) |
| 2022 | $413.73 | 16 | Integra LifeSciences Corporation ($193.53) |
| 2021 | $67,476 | 24 | PolarityTE, Inc. ($53,080) |
| 2020 | $216,987 | 25 | Integra LifeSciences Corporation ($146,677) |
| 2019 | $163,125 | 39 | Integra LifeSciences Corporation ($91,949) |
| 2018 | $223,657 | 25 | Integra LifeSciences Corporation ($197,776) |
| 2017 | $72,754 | 4 | Celgene Corporation ($72,661) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Extra Cellular Matrix | ||||||
| 08/07/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $22.45 | General |
| 07/17/2024 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $20.24 | General |
| 07/10/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Pharma Products | ||||||
| 06/19/2024 | Urgo Medical North America, LLC | VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP (Device), DRAWTEX HYDROCONDUCTIVE WOUND DRESSING WITH LEVAFIBER 4X4, URGOK2 | Food and Beverage | In-kind items and services | $122.80 | General |
| Category: WOUND CLEANSER | ||||||
| 05/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: ANTIBIOTIC | ||||||
| 05/06/2024 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Extra Cellular Matrix | ||||||
| 04/24/2024 | Solventum Corporation | ACTIV.A.C. (Device), PROMOGRAN PRISMA | Food and Beverage | Cash or cash equivalent | $34.14 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 03/06/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: ANTIBIOTIC | ||||||
| 02/29/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Pharma Products | ||||||
| 01/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: ANTIBIOTIC | ||||||
| 12/22/2023 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Recon-Skin and Wound | ||||||
| 12/06/2023 | ETS Wound Care LLC | MIRRAGEN ADVANCED WOUND MATRIX (Device) | Food and Beverage | Cash or cash equivalent | $79.99 | General |
| Category: Synthetic, absorbable skin substitute matrix | ||||||
| 11/15/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: ANTIBIOTIC | ||||||
| 10/30/2023 | ETS Wound Care LLC | MIRRAGEN ADVANCED WOUND MATRIX (Device) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Synthetic, absorbable skin substitute matrix | ||||||
| 09/28/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: ANTIBIOTIC | ||||||
| 09/28/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: ANTIBIOTIC | ||||||
| 07/31/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ANTIBIOTIC | ||||||
| 06/12/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Wound Care | ||||||
| 04/13/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ANTIBIOTIC | ||||||
| 04/10/2023 | Smith+Nephew, Inc. | RENASYS GO v2 HOME (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 03/20/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $22.85 | General |
| Category: Wound Care | ||||||
| 02/13/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: ANTIBIOTICS | ||||||
| 02/03/2023 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $158.18 | General |
| Category: Recon-Skin and Wound | ||||||
| 02/02/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ANTIBIOTIC | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| T-PMXDFU-01 | Integra LifeSciences Corporation | $168,808 | 12 |
| CAOTT009 | Integra LifeSciences Corporation | $149,465 | 10 |
| RCT DFU | PolarityTE, Inc. | $126,372 | 16 |
| CCT-PDA-002-DFU-002 | Celgene Corporation | $72,661 | 1 |
| T-PMXDFU-1 | Integra LifeSciences Corporation | $63,162 | 1 |
| CAOTT028 | Integra LifeSciences Corporation | $48,283 | 1 |
| T-PMXDFU-01 | TEI Medical Inc. | $37,341 | 5 |
| A Multiple-dose, Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dysport for the Treatment of Pain Associated With Hallux Abducto Valgus | Ipsen Innovation | $32,363 | 13 |
| T-PMXDFU-001 | Integra LifeSciences Corporation | $17,582 | 2 |
| RCT VLU | PolarityTE, Inc. | $6,600 | 2 |
| A Multicenter, Prospective, Randomized, Open-Label Study with a Crossover Extension to Evaluate the Safety and Efficacy of GrafixPL PRIME for the Treatment of Chronic Venous Leg Ulcers | Smith+Nephew, Inc. | $360.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 354 | 745 | $76,960 | $43,616 |
| 2022 | 12 | 403 | 888 | $94,381 | $53,189 |
| 2021 | 12 | 652 | 1,307 | $135,346 | $80,890 |
| 2020 | 10 | 381 | 638 | $56,843 | $37,821 |
Total Patients
1,790
Total Services
3,578
Medicare Billing
$215,516
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 20 | 106 | $14,310 | $9,663 | 67.5% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 38 | 90 | $14,850 | $6,676 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 83 | $12,450 | $6,477 | 52.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 69 | 156 | $10,140 | $6,093 | 60.1% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 56 | 125 | $5,625 | $3,617 | 64.3% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 25 | 42 | $6,300 | $2,735 | 43.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $3,780 | $2,710 | 71.7% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 12 | 21 | $3,360 | $2,442 | 72.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 39 | $3,120 | $1,932 | 61.9% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2023 | 14 | 35 | $1,925 | $638.65 | 33.2% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 15 | 20 | $1,100 | $631.00 | 57.4% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 23 | 98 | $13,230 | $9,185 | 69.4% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 40 | 120 | $19,800 | $9,064 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 112 | $16,800 | $8,543 | 50.9% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 75 | 201 | $13,065 | $7,500 | 57.4% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 11 | 50 | $8,000 | $5,832 | 72.9% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 67 | 153 | $6,885 | $4,243 | 61.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $4,590 | $3,115 | 67.9% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 36 | 48 | $7,200 | $3,086 | 42.9% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 12 | 12 | $2,100 | $1,445 | 68.8% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2022 | 14 | 27 | $1,485 | $504.84 | 34.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 14 | 14 | $770.00 | $453.60 | 58.9% |
| 11719 | Trimming of fingernails or toenails | Office | 2022 | 12 | 19 | $456.00 | $217.96 | 47.8% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Office | 2021 | 32 | 132 | $21,120 | $15,866 | 75.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 155 | $22,770 | $12,149 | 53.4% |
About Dr. Felix Sigal, DPM
Dr. Felix Sigal, DPM is a Foot & Ankle Surgery healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710974522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Felix Sigal, DPM has received a total of $745,512 in payments from pharmaceutical and medical device companies, with $330.78 received in 2024. These payments were reported across 160 transactions from 27 companies. The most common payment nature is "" ($722,998).
As a Medicare-enrolled provider, Sigal has provided services to 1,790 Medicare beneficiaries, totaling 3,578 services with total Medicare billing of $215,516. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot & Ankle Surgery
- Location Los Angeles, CA
- Active Since 10/06/2005
- Last Updated 10/11/2022
- Taxonomy Code 213ES0103X
- Entity Type Individual
- NPI Number 1710974522
Products in Payments
- PRIMATRIX (Device) $484,642
- SkinTE (Biological) $80,081
- PDA002 (Drug) $72,661
- DYSPORT (Drug) $26,363
- GRAFIX PL (Biological) $19,508
- Dysport (Drug) $6,000
- NUZYRA (Drug) $418.05
- Grafix PL PRIME (Biological) $391.87
- Integra (Device) $373.77
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $336.81
- MIRRAGEN ADVANCED WOUND MATRIX (Device) $279.99
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP (Device) $122.80
- GrafixPL (Biological) $122.09
- Santyl (Drug) $115.37
- OMNIGRAFT (Device) $100.76
- COLLAGENASE SANTYL (Drug) $78.95
- Peripheral Orbital Atherectomy System (Device) $76.66
- Puraply (Medical Supply) $59.61
- ACTIVAC (Device) $59.16
- ACTIV.A.C. (Device) $48.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Foot & Ankle Surgery Doctors in Los Angeles
Gabriel Halperin, Dpm, DPM
Foot & Ankle Surgery — Payments: $150,321
Foot & Ankle Surgery $150,321
Edward Kim, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $50,472
Foot & Ankle Surgery $50,472
Brian Hong, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $21,351
Foot & Ankle Surgery $21,351
Matt Cikra, Dpm, DPM
Foot & Ankle Surgery — Payments: $12,991
Foot & Ankle Surgery $12,991
Lucian Feraru, Dpm, DPM
Foot & Ankle Surgery — Payments: $11,619
Foot & Ankle Surgery $11,619
Dr. Dustin Rilling, Dpm, DPM
Foot & Ankle Surgery — Payments: $7,860
Foot & Ankle Surgery $7,860